Peptide Research Glossary
A plain-language reference covering peptide chemistry, analytical testing, pharmacology, and laboratory handling. Written for researchers, not marketers.
A
3 termsAmino Acid
An organic molecule containing both an amino group (-NH2) and a carboxyl group (-COOH), serving as the fundamental building block of peptides and proteins. Twenty standard amino acids are encoded in the human genome, and their sequence determines a peptide's receptor binding characteristics, three-dimensional conformation, and activity in research systems.
AMPK (AMP-Activated Protein Kinase)
A heterotrimeric serine/threonine kinase that functions as a master sensor of cellular energy status. AMPK is activated allosterically by elevated AMP:ATP ratios and by upstream kinases including LKB1 and CaMKK2. Once active, it phosphorylates substrates governing fatty acid oxidation, glucose transporter translocation, mitochondrial biogenesis, and mTORC1 inhibition. AICAR (Acadesine) and MOTS-c are both investigated as AMPK-activating compounds in preclinical metabolic research.
Analogue
A synthetically produced compound that shares structural similarity with a naturally occurring molecule but incorporates deliberate chemical modifications. These modifications typically target half-life extension, improved receptor selectivity, or enhanced metabolic stability. Research peptides are frequently analogues of endogenous hormones: Tesamorelin is an analogue of GHRH; IGF-1 LR3 is an analogue of native IGF-1.
Related Products
B
5 termsBacteriostatic Water (BAC Water)
Sterile water for injection containing 0.9% benzyl alcohol as an antimicrobial preservative. The benzyl alcohol inhibits microbial growth following initial vial puncture, allowing multiple withdrawals over a defined storage period without compromising sterility. It is the standard reconstitution medium for the majority of lyophilised research peptides.
Related Products
BDNF (Brain-Derived Neurotrophic Factor)
The most widely expressed neurotrophin in the adult CNS, regulating neuronal survival, dendritic arborisation, synaptic plasticity, and adult hippocampal neurogenesis through TrkB receptor activation. BDNF signalling is examined in the context of multiple research peptides including Semax, ADAMAX, and P21, with published in vitro studies investigating their modulation of BDNF transcription in neuronal cell preparations.
Related Products
Binding Affinity
The strength of the non-covalent interaction between a ligand and its target receptor, quantified by the dissociation constant (Kd). A lower Kd value indicates tighter binding and higher affinity. Binding affinity is distinct from potency: a compound may bind with high affinity but produce only partial activation, or bind loosely but fully activate the receptor at achievable concentrations.
Bioavailability
The fraction of an administered compound that reaches the systemic circulation in an active, unmodified form. Bioavailability is governed by route of administration, first-pass metabolism, enzymatic degradation, and membrane permeability. PEGylation, the covalent attachment of polyethylene glycol chains as applied to PEG-MGF, is a chemical strategy investigated in preclinical research for its effects on peptide bioavailability and circulating half-life.
Related Products
Blood-Brain Barrier (BBB)
A highly selective endothelial barrier formed by specialised brain microvascular endothelial cells joined by tight junctions, separating the systemic circulation from the CNS parenchyma. The BBB restricts the passive diffusion of most peptides and proteins into the brain, presenting a fundamental challenge in neuropeptide research. Structural modifications such as the adamantane moiety in ADAMAX and lipidation strategies are investigated in preclinical research for their effects on CNS penetration.
Related Products
C
6 termscAMP (Cyclic Adenosine Monophosphate)
A ubiquitous intracellular second messenger generated by adenylyl cyclase following Gs-coupled receptor activation. cAMP mediates downstream signalling from GHRH-R, VPAC receptors, melanocortin receptors, and many others by activating protein kinase A (PKA). GHRH-R agonists such as Sermorelin and CJC-1295 drive cAMP accumulation in pituitary somatotrophs, linking receptor occupancy to GH gene expression and secretion.
Cardiolipin
A dimeric phospholipid (formally a diphosphatidylglycerol) found at high concentration almost exclusively in the inner mitochondrial membrane, where it stabilises electron transport chain supercomplexes and maintains cristae curvature. Cardiolipin peroxidation and translocation to the outer membrane are early events in mitochondrial apoptotic signalling. SS-31 (Elamipretide) is a mitochondria-targeting tetrapeptide that binds selectively to cardiolipin at the inner membrane.
Related Products
CAS Number
A unique numerical identifier assigned by the Chemical Abstracts Service to every registered chemical substance. CAS numbers provide an unambiguous reference for compound identification across suppliers, databases, and the published literature, independent of trade names or synonyms. For example, GHRP-6 carries CAS 87616-84-0 and Gonadorelin carries CAS 33515-09-2.
Certificate of Analysis (COA)
A document issued for each manufactured batch of a research compound, reporting the results of identity, purity, and quality testing. A CoA typically includes HPLC purity data, mass spectrometry confirmation of molecular weight, physical appearance, and manufacturing lot information. CoAs are the primary means by which researchers verify compound quality before use.
cGMP (Current Good Manufacturing Practice)
A regulatory framework governing the systems, facilities, processes, and controls required in the production of pharmaceutical and research compounds. cGMP compliance ensures consistent quality, traceability, and contamination control across manufacturing batches and is a recognised benchmark of production quality for research reagents.
Collagen Synthesis
The multi-step cellular process by which collagen molecules are assembled, beginning with procollagen gene transcription and translation, followed by post-translational hydroxylation of proline and lysine residues, triple helix formation within the endoplasmic reticulum, secretion, and extracellular fibril assembly. GHK-Cu, PAL-GHK, and Matrixyl are investigated in dermal fibroblast preparations examining their modulation of procollagen synthesis and matrix turnover markers.
Related Products
D
5 termsD-Amino Acid
A stereoisomeric form of the standard L-amino acid, in which the side chain is oriented in a mirror-image configuration relative to the alpha-carbon. Because proteolytic enzymes have evolved to cleave L-configured peptide bonds, incorporation of D-amino acids confers substantial resistance to enzymatic degradation. Dermorphin incorporates D-Ala at position 2, GHRP-2 features D-2-Naphthylalanine at position 3, and FOXO4-DRI employs a complete D-retro-inverso backbone.
Related Products
Depot Effect
The prolonged release of a compound from its injection site into systemic circulation over an extended period. The depot effect occurs when a compound forms a local reservoir in subcutaneous tissue or muscle, releasing gradually rather than absorbing immediately. Some peptide formulations and esters are deliberately designed to exploit this effect to reduce dosing frequency in research protocols.
Disulfide Bridge
A covalent bond formed between the thiol groups (-SH) of two cysteine residues through oxidation, producing a -S-S- linkage that introduces a structural constraint into the peptide backbone. Disulfide bonds are critical determinants of peptide conformation and receptor binding geometry. Oxytocin (Cys1-Cys6 tocin ring), Orexin A (Cys6-Cys12 and Cys7-Cys14 bridges), and AOD-9604 (Cys7-Cys14) each feature disulfide bonds central to their pharmacological activity.
Dopaminergic Neuron
A neuron that synthesises dopamine via the sequential action of tyrosine hydroxylase and DOPA decarboxylase, with major populations in the substantia nigra pars compacta and ventral tegmental area. Dopaminergic neuron viability and axonal projection integrity are central endpoints in Parkinson's disease research models. DNSP-11, a GDNF pro-domain-derived peptide, is investigated in preclinical 6-OHDA and related dopaminergic neuron survival studies.
Related Products
Dose-Response Relationship
The quantitative relationship between the concentration or amount of a compound and the magnitude of the biological response it produces. Dose-response data are typically plotted as a sigmoidal curve from which EC50 (half-maximal effective concentration) and Emax (maximum response) are derived. Establishing dose-response relationships is a foundational step in characterizing any research compound's activity and selectivity.
Related Products
E
4 termsEC50
The molar concentration of a compound required to produce 50% of its maximum observed effect in a given assay system. EC50 is a standard measure of in vitro potency. Lower EC50 values indicate greater potency. EC50 values are assay- and cell-type-dependent and should not be compared across different experimental systems without accounting for these variables.
Endogenous
Synthesized and originating from within an organism. Endogenous peptides are produced by the body's own cells and tissues as part of normal physiological regulation. GHRH, ghrelin, oxytocin, and BPC-157 (derived from gastric juice protein) are examples of endogenous peptides. Research analogues are typically engineered modifications of endogenous sequences.
Exogenous
Originating from outside a biological organism. An exogenous compound is introduced from an external source rather than produced endogenously. All research peptides supplied for laboratory use are exogenous compounds. The term is often used in the context of distinguishing administered compounds from the body's own endogenous production.
Related Products
Extracellular Matrix (ECM)
The three-dimensional non-cellular network of structural proteins (collagens, elastin, fibronectin, laminin) and polysaccharides (glycosaminoglycans, proteoglycans) surrounding cells in tissues. The ECM provides both mechanical support and biochemical signalling cues to resident cell populations. GHK-Cu and PAL-GHK are investigated in preclinical dermatological research examining MMP regulation and matrix remodelling dynamics.
Related Products
G
7 termsGABAergic Signalling
Neurotransmission mediated by gamma-aminobutyric acid (GABA), the principal fast inhibitory neurotransmitter in the mammalian CNS. GABA signals through ionotropic GABA-A receptors (chloride channels) and metabotropic GABA-B receptors (Gi-coupled GPCRs) to hyperpolarise target neurons and reduce firing probability. Published in vitro electrophysiology studies with Selank (TP-7) have examined its modulation of GABAergic inhibitory postsynaptic currents in hippocampal neuron preparations.
Related Products
GH Pulse
A discrete episode of growth hormone secretion from pituitary somatotrophs into the systemic circulation. GH is released in a pulsatile pattern governed by the interplay of hypothalamic GHRH and somatostatin, with pulse amplitude, frequency, and interpulse nadir as the key measurable parameters. Published rodent studies with secretagogues such as GHRP-6 and CJC-1295 (No DAC) have characterised these GH pulse dynamics following exogenous administration.
Related Products
Ghrelin Receptor (GHS-R1a)
Growth Hormone Secretagogue Receptor type 1a, a Gq-coupled G protein-coupled receptor expressed on pituitary somatotrophs and hypothalamic neurons. GHS-R1a activation triggers phospholipase C-mediated intracellular calcium mobilisation, stimulating GH granule exocytosis. Synthetic GHS-R1a agonists in preclinical use include GHRP-6, GHRP-2, Ipamorelin, and Hexarelin.
Related Products
GHRH (Growth Hormone-Releasing Hormone)
A 44-amino acid hypothalamic peptide that stimulates GH synthesis and secretion from the anterior pituitary via the GHRH receptor (GHRHR). Endogenous GHRH is released in pulses, driving the natural pulsatile pattern of GH secretion. Research analogues including Sermorelin (a truncated 1-29 fragment) and CJC-1295 are used to study GHRH receptor pharmacology and GH axis regulation.
GHRH Receptor (GHRH-R)
Growth Hormone-Releasing Hormone Receptor, a class B G protein-coupled receptor expressed on anterior pituitary somatotrophs. GHRH-R activation by endogenous GHRH or synthetic analogues triggers adenylyl cyclase activation and cAMP/PKA-mediated signalling, stimulating both GH synthesis and secretion. Sermorelin, CJC-1295, and Tesamorelin are each structurally distinct GHRH-R agonists used in preclinical research.
Related Products
Gonadotropin
A glycoprotein hormone secreted by anterior pituitary gonadotroph cells in response to pulsatile GnRH signalling. The two principal gonadotropins are luteinizing hormone (LH) and follicle-stimulating hormone (FSH), each controlling distinct aspects of gonadal function. Gonadorelin (synthetic GnRH) is the endogenous hypothalamic decapeptide whose pulsatile release controls the differential synthesis and secretion of both gonadotropins from pituitary gonadotroph cells.
Related Products
Growth Hormone Secretagogue (GHS)
A compound that stimulates the release of growth hormone (GH) from anterior pituitary somatotroph cells. Secretagogues are classified by their receptor target: ghrelin receptor (GHS-R1a) agonists include GHRP-6, GHRP-2, Ipamorelin, and Hexarelin, while GHRH receptor agonists include Sermorelin, CJC-1295 (with and without DAC), and Tesamorelin, each representing a mechanistically distinct approach to somatotroph stimulation.
Related Products
H
3 termsHalf-Life
The time required for the circulating concentration of a compound to decrease by 50% through metabolic clearance, enzymatic degradation, or excretion. Half-life is a key pharmacokinetic parameter in preclinical research that governs dosing intervals in experimental protocols. CJC-1295 With DAC was engineered with an albumin-binding DAC conjugate specifically to extend its half-life relative to unmodified GHRH analogues.
Related Products
HPG Axis
The hypothalamic-pituitary-gonadal axis, a hierarchical neuroendocrine feedback circuit in which pulsatile hypothalamic GnRH stimulates pituitary gonadotropin (LH and FSH) secretion, which drives gonadal steroidogenesis and gametogenesis. Gonadal sex steroids feed back to both the hypothalamus and pituitary, regulating GnRH pulse frequency and amplitude. Gonadorelin and Kisspeptin-10 are key research tools for investigating HPG axis regulation in preclinical models.
Related Products
HPLC (High-Performance Liquid Chromatography)
An analytical technique that separates peptide mixtures by passing them through a stationary phase column under high pressure, resolving components by their differential affinity for the column. HPLC is the standard method for determining peptide purity, identifying degradation products, and verifying batch-to-batch consistency.
I
6 termsIGF-1 (Insulin-Like Growth Factor 1)
A 70-amino acid polypeptide produced primarily in hepatocytes in response to growth hormone signalling. IGF-1 acts through the IGF-1 receptor (IGF-1R) to mediate many of the downstream anabolic and mitogenic effects of the GH/IGF-1 axis. Structurally modified research analogues include IGF-1 LR3 (83 amino acids, N-terminal extension) and IGF-1 DES (67 amino acids, N-terminal truncation).
IGFBP (Insulin-Like Growth Factor Binding Protein)
A family of six high-affinity carrier proteins (IGFBP-1 through IGFBP-6) that sequester circulating IGF-1, regulating its bioavailability, half-life, and tissue distribution. Both IGF-1 LR3 and IGF-1 DES were engineered with reduced IGFBP binding affinity relative to native IGF-1, making them valuable tools for studying IGF-1R signalling in isolation from IGFBP-dependent regulatory mechanisms.
In Vitro
Latin for 'in glass', refers to experiments conducted in controlled laboratory environments outside a living organism, typically using cell cultures, isolated tissue preparations, or cell-free biochemical systems. In vitro studies enable precise characterisation of receptor binding kinetics, intracellular signalling cascades, and compound-target interactions under controlled experimental conditions.
In Vivo
Latin for 'in the living', refers to experiments conducted within a living organism, typically rodent models. In vivo studies examine whole-system pharmacokinetics, tissue distribution, and physiological responses that cannot be fully modelled in cell culture. Published in vivo rodent studies with GHRP-6 and Sermorelin have characterised GH pulse dynamics within the somatotropic axis.
Intramuscular (IM)
A parenteral route of administration in which a compound is injected directly into skeletal muscle tissue. The vascularized nature of muscle allows reliable and relatively rapid absorption. IM injection typically produces faster absorption than subcutaneous administration but slower than intravenous. In research settings, IM administration is used when consistent absorption and depot avoidance are required.
IRB (Institutional Review Board)
A formally designated committee in the United States required under federal regulations (45 CFR 46 and 21 CFR 56) to review, approve, and oversee research involving human subjects. IRBs evaluate the ethical acceptability of proposed research protocols, risk-benefit ratios, and informed consent procedures. Any research involving human subjects requires prospective IRB review and approval prior to initiation.
K
1 termsKd (Dissociation Constant)
A quantitative measure of the equilibrium between a bound receptor-ligand complex and its dissociated components. Kd represents the ligand concentration at which 50% of receptors are occupied at equilibrium. A lower Kd indicates stronger binding and higher affinity. Kd values in the nanomolar (nM) range are considered high affinity; picomolar (pM) range indicates extremely high affinity.
L
2 termsLigand
Any molecule that forms a specific, non-covalent complex with a target protein such as a receptor, enzyme, or transporter. In peptide research, the ligand is typically the peptide itself. Ligand binding may activate, inhibit, or modulate the target's function depending on the binding site and conformational change induced. Ligand-receptor interaction specificity is governed by complementary shape, charge distribution, and hydrophobic character.
Lyophilisation (Freeze-Drying)
A freeze-drying process that removes water from a peptide solution under vacuum, producing a stable, dry powder with a significantly extended shelf life relative to liquid formulations. Lyophilised peptides resist degradation during storage and transport more effectively than solutions and require reconstitution in an appropriate solvent before laboratory use.
M
9 termsMAPK/ERK Pathway
The mitogen-activated protein kinase/extracellular signal-regulated kinase cascade, a widely conserved signalling pathway that transduces receptor activation into transcriptional responses governing cell proliferation, differentiation, and survival. MAPK/ERK signalling is investigated downstream of IGF-1R, c-Met, GHS-R1a, and melanocortin receptor activation. Dihexa research has specifically examined HGF/c-Met-dependent ERK phosphorylation in hippocampal neuronal preparations.
Related Products
Mass Spectrometry (MS)
An analytical technique that ionizes a compound and measures the mass-to-charge ratio (m/z) of resulting ions to determine molecular weight and structural composition. In peptide quality control, MS is coupled with chromatography (LC-MS or MS-UPLC) and used alongside HPLC to confirm compound identity. It verifies that the molecular weight of the compound matches the theoretical value for the stated sequence, detecting synthesis errors, truncations, or adducts that HPLC alone cannot identify.
Matrikine
A bioactive peptide fragment released by the enzymatic degradation of extracellular matrix proteins, capable of binding cell surface receptors and modulating matrix biology in an autocrine or paracrine manner. Matrikines represent a feedback mechanism linking matrix remodelling activity to cellular responses including collagen synthesis and MMP expression. Matrixyl (Palmitoyl Pentapeptide-4) contains the KTTKS matrikine sequence originally identified as a procollagen I cleavage product.
Melanocortin Receptor
A family of five G protein-coupled receptors (MC1R-MC5R) activated by peptide hormones derived from pro-opiomelanocortin (POMC) processing, including alpha-MSH, beta-MSH, and ACTH. Each receptor subtype has a distinct anatomical distribution and physiological role, from pigmentation (MC1R) to adrenal steroidogenesis (MC2R) to central energy balance and autonomic function (MC3R, MC4R). Research compounds spanning the family include KPV (MC1R), ACTH 1-39 (MC2R), and PT-141/Bremelanotide (MC3R/MC4R).
Related Products
Mitochondrial-Derived Peptide (MDP)
A bioactive peptide encoded within short open reading frames embedded in the mitochondrial genome, a circular DNA molecule previously thought to encode only 13 respiratory chain polypeptides, 22 tRNAs, and 2 rRNAs. MDPs constitute a newly recognised class of retrograde signalling molecules that communicate mitochondrial status to nuclear and extramitochondrial compartments. Humanin (encoded within MT-RNR2) and MOTS-c (encoded within MT-RNR1) are the two founding members of this peptide class.
Molecular Formula
A notation specifying the exact number and type of each atom present in one molecule of a compound. Molecular formulas are used alongside molecular weight and CAS number to unambiguously identify a compound. For peptides, the formula reflects the complete amino acid composition including any chemical modifications. BPC-157 has the molecular formula C62H98N16O22; TB-500 (Thymosin Beta-4) has C212H350N56O78S.
Molecular Weight (MW)
The sum of the atomic masses of all atoms in a molecule, expressed in grams per mole (g/mol). Molecular weight is a key identifier for confirming peptide identity during quality control and is reported on every Certificate of Analysis. Research peptides span a wide range, from dipeptides such as Vilon (275.30 g/mol) to large proteins such as IGF-1 LR3 (9117.60 g/mol).
MS-UPLC
Mass Spectrometry coupled with Ultra-Performance Liquid Chromatography, an advanced analytical method combining rapid chromatographic separation with mass-based molecular identification. MS-UPLC confirms both the purity and the exact molecular identity of a peptide in a single analysis run, providing a higher level of analytical confidence than HPLC alone.
Myoblast
A mononucleated precursor cell derived from activated satellite cells that undergoes transit amplification before fusing with existing fibres or with other myoblasts to form multinucleated myotubes. C2C12 myoblast cell lines are the standard in vitro model for studying skeletal muscle cell differentiation. Published research with IGF-1 LR3 and MGF has examined receptor signalling and differentiation markers in myoblast culture systems.
N
4 termsN-terminus / C-terminus
The two chemically distinct ends of a peptide chain. The N-terminus carries a free alpha-amino group; the C-terminus carries a free carboxyl group. By convention, peptide sequences are written and numbered from N-terminus to C-terminus. Terminal modifications, such as N-terminal acetylation or C-terminal amidation, are commonly applied to increase proteolytic resistance and extend half-life.
Neuropeptide
A peptide molecule produced and released by neurons that functions as a signalling molecule within the nervous system, acting through G protein-coupled receptors on target cells. Neuropeptides modulate neurotransmission, neuroendocrine function, and neural circuit activity with greater temporal persistence than classical neurotransmitters. Research compounds in this class include VIP, Orexin A, Orexin B, Oxytocin, DSIP, Kisspeptin, and several others.
Neurotrophic Factor
A class of secreted polypeptides that regulate the survival, growth, differentiation, and synaptic maintenance of neurons. Major families include the neurotrophins (BDNF, NGF, NT-3, NT-4/5), CNTF-family cytokines, and GDNF-family ligands. Semax and ADAMAX are investigated for their interaction with BDNF expression and TrkB signalling, while DNSP-11 is derived from the pro-domain of GDNF.
Related Products
NF-kB Pathway
Nuclear Factor kappa-light-chain-enhancer of activated B cells, a family of dimeric transcription factors (RelA/p65, RelB, c-Rel, p50, p52) that regulate inflammatory and immune gene expression programmes. NF-kB is held inactive in the cytoplasm by IkB inhibitor proteins and is released following IKK-mediated IkB phosphorylation and degradation downstream of TLR, TNF receptor, and IL-1R signalling. Published in vitro studies with KPV have examined its interaction with NF-kB-dependent cytokine signalling in intestinal epithelial preparations.
Related Products
P
9 termsPEGylation
The covalent attachment of one or more polyethylene glycol (PEG) polymer chains to a peptide molecule. PEGylation increases hydrodynamic radius, reducing renal clearance and protecting against enzymatic degradation, resulting in significantly extended circulating half-life. The degree of half-life extension depends on PEG molecular weight and attachment site. PEG-MGF (PEGylated Mechano Growth Factor) is a commonly studied PEGylated research peptide.
Related Products
Peptide
A short chain of amino acids linked by peptide bonds, typically comprising between 2 and 50 residues. Peptides are distinguished from proteins by their shorter length and are widely used in preclinical research as receptor ligands, signalling probes, and pharmacological tool compounds. GHRP-6 and Ipamorelin are hexapeptide and pentapeptide examples respectively.
Peptide Bond
The covalent amide bond formed between the alpha-carboxyl group of one amino acid and the alpha-amino group of the next, with the elimination of a water molecule (condensation reaction). Peptide bonds exhibit partial double-bond character due to resonance delocalization, making them planar and relatively rigid. This planarity is a key determinant of the backbone geometry and secondary structure of a peptide chain.
Peptidomimetic
A synthetic compound that mimics the structural and pharmacological features of a natural peptide while incorporating non-peptidic elements, such as modified backbones, D-amino acids, cyclic constraints, or small molecule scaffolds, to confer improved metabolic stability, receptor selectivity, or pharmacokinetic characteristics. Adipotide exemplifies this approach with its chimeric architecture combining a phage display-derived vascular targeting motif with a D-enantiomer mitochondrial membrane-disrupting domain.
Related Products
PI3K/Akt Pathway
A major intracellular signalling cascade activated downstream of receptor tyrosine kinases including IGF-1R and c-Met. Phosphoinositide 3-kinase (PI3K) generates PIP3 at the plasma membrane, recruiting and activating the serine/threonine kinase Akt, which regulates cell survival, protein synthesis, and glucose metabolism. This pathway has been examined in published in vitro research with IGF-1 LR3 and Dihexa.
Related Products
PKA (Protein Kinase A)
A serine/threonine kinase activated when cAMP binds to its regulatory subunits, releasing the catalytic subunits. PKA phosphorylates downstream targets including CREB (cAMP response element-binding protein), directly coupling receptor activation to transcriptional regulation. In the somatotropic axis, GHRH-R activation by compounds such as Tesamorelin drives cAMP/PKA-mediated GH gene expression in anterior pituitary somatotroph preparations.
Preclinical Research
The stage of scientific investigation conducted prior to clinical trials, encompassing in vitro cell-based studies, in vivo animal models, and pharmacokinetic characterisation. Preclinical research establishes a compound's receptor pharmacology, mechanism of action, and initial safety profile, forming the scientific foundation for any subsequent translational investigation.
Pulsatile Release
The physiological pattern of intermittent secretion in which hormones are released in discrete pulses rather than at a constant rate. Growth hormone secretion is strongly pulsatile, with the majority of daily GH output occurring during sleep in 4 to 6 major pulses. The pulsatile pattern is generated by alternating hypothalamic GHRH stimulation and somatostatin inhibition. Research peptides that amplify GH release through the GHRH or GHS-R1a pathways are studied in the context of whether they preserve or alter this pulsatile architecture.
Related Products
Purity
The proportion of the target compound present in a sample relative to all impurities, expressed as a percentage. Peptide purity is critical for research reproducibility; impurities can introduce confounding variables into experimental results and invalidate comparative studies. Research grade peptides are typically manufactured to a guaranteed purity of 98% or above, verified by HPLC.
R
4 termsReceptor
A protein that selectively binds a specific ligand and transduces that binding event into an intracellular signal. Receptors may be membrane-bound (e.g., G protein-coupled receptors, receptor tyrosine kinases, ion channel receptors) or intracellular (e.g., nuclear receptors). Ligand binding induces a conformational change in the receptor that activates downstream signaling cascades. Receptor distribution across tissues determines the anatomical targets of a given peptide.
Receptor Agonist
A molecule that binds to a receptor and activates its associated intracellular signalling cascade, mimicking or exceeding the response produced by the endogenous ligand. Agonists are fundamental pharmacological tools for characterising receptor function and downstream signalling pathways. Ipamorelin is a selective GHS-R1a agonist, while Gonadorelin is a full GnRH receptor agonist.
Related Products
Receptor Antagonist
A molecule that binds to a receptor without activating it, occupying the binding site and preventing endogenous ligand access. Antagonists are used in preclinical research to characterise receptor function by selectively silencing specific signalling pathways and dissecting their contributions to observed biological responses. Follistatin 344 acts as a ligand sequestration agent, neutralising TGF-beta superfamily members including Myostatin.
Related Products
Reconstitution
The process of dissolving a lyophilised peptide powder into aqueous solution prior to laboratory use. Reconstitution involves adding an appropriate volume of Bacteriostatic Water or dilute acetic acid to the vial and allowing complete dissolution. Solvent selection depends on the peptide's charge and solubility profile; basic peptides typically dissolve well in water, while more hydrophobic sequences may require dilute acetic acid.
Related Products
S
11 termsSarcomere
The fundamental contractile unit of striated muscle, bounded by Z-discs and containing interdigitating actin thin filaments and myosin thick filaments. Sarcomere organisation and composition are central research topics in skeletal muscle cell biology, with signalling pathways governing fibre-type switching and hypertrophic responses investigated using compounds such as Follistatin 344 and GDF-8 in preclinical model systems.
Satellite Cell
A quiescent muscle stem cell population residing between the basal lamina and sarcolemma of mature skeletal muscle fibres. Satellite cells are activated in response to mechanical loading or chemical stimuli and contribute to muscle fibre maintenance through asymmetric division, giving rise to self-renewing stem cells and committed myoblast progeny. Published in vitro research with MGF has investigated satellite cell proliferation kinetics in skeletal muscle cell preparations.
Related Products
Schedule Status (DEA)
A classification assigned by the US Drug Enforcement Administration (DEA) under the Controlled Substances Act (CSA) indicating the regulatory status of a substance based on its accepted medical use and potential for abuse or dependence. Most research peptides are not DEA-scheduled controlled substances, but researchers should verify the current federal and state regulatory status of any compound before procurement. Schedule status can change via DEA rulemaking.
Senescent Cell
A cell that has undergone permanent cell cycle arrest following replicative exhaustion, oncogene activation, or DNA damage, while remaining metabolically active and secreting a pro-inflammatory senescence-associated secretory phenotype (SASP) comprising cytokines, proteases, and growth factors. Senescent cell accumulation is a hallmark of ageing tissues and a central topic in geroscience research. FOXO4-DRI is a D-retro-inverso peptide investigated as a selective senolytic tool in aged rodent models.
Related Products
Sequence
The precise linear order of amino acid residues in a peptide chain, written from N-terminus to C-terminus using one-letter or three-letter amino acid codes. Sequence entirely determines primary structure and, together with environmental conditions, governs the peptide's folding, stability, receptor interactions, and biological activity. A single amino acid substitution can substantially alter potency, selectivity, or metabolic stability. BPC-157 has the sequence Gly-Glu-Pro-Pro-Pro-Gly-Lys-Pro-Ala-Asp-Asp-Ala-Gly-Leu-Val.
SMAD Signalling
The canonical intracellular signal transduction pathway downstream of TGF-beta superfamily receptors. Upon receptor activation, R-SMADs (SMAD2/3 for activin/myostatin; SMAD1/5/8 for BMPs) are phosphorylated, form complexes with the co-SMAD SMAD4, and translocate to the nucleus to regulate target gene transcription. Published in vitro studies with GDF-8 have characterised SMAD2/3 phosphorylation kinetics in myoblast cell preparations.
Related Products
Solid-Phase Peptide Synthesis (SPPS)
A chemical method for assembling peptides in which the growing chain is anchored to an insoluble resin support, with amino acids added sequentially from C-terminus to N-terminus. SPPS enables precise control over sequence, purity, and the incorporation of non-natural residues such as the D-alanine found in Dermorphin or the D-2-Naphthylalanine in GHRP-2.
Solubility
The maximum concentration of a compound that can dissolve in a given solvent at a specified temperature and pH. Peptide solubility is sequence-dependent and influenced by charge, hydrophobicity, and secondary structure propensity. Most research peptides dissolve readily in aqueous solvents such as bacteriostatic water. Those with high hydrophobic content may require initial dissolution in a small volume of dilute acetic acid or acetonitrile before aqueous dilution.
Related Products
Somatotroph
A specialised secretory cell type in the anterior pituitary gland responsible for synthesising, storing, and releasing growth hormone. Somatotrophs express both GHS-R1a and GHRH-R, making them the convergence point for the two principal GH secretagogue receptor systems. The CJC-1295 + Ipamorelin combination targets both receptor populations on the same somatotroph, activating distinct but synergistic second messenger cascades.
Related Products
Structure-Activity Relationship (SAR)
The systematic investigation of how specific chemical modifications to a compound alter its biological activity, receptor binding affinity, selectivity profile, or pharmacokinetic behaviour. SAR studies are the cornerstone of rational peptide analogue design. The progression from GHRP-6 (D-Trp at position 2) through GHRP-2 (D-2-Naphthylalanine at position 2) to Ipamorelin (N-terminal Aib substitution) illustrates SAR-driven optimisation of GHS-R1a selectivity across three successive secretagogue generations.
Related Products
Subcutaneous (SC)
A parenteral route of administration involving injection into the subcutaneous tissue layer, situated between the dermis and the underlying muscle fascia. SC injection is the most common administration route for peptide research protocols due to ease of access and reliable, consistent absorption. Injection is typically performed at a 45-degree angle with a short, fine-gauge needle (27 to 30 gauge, 0.5 inch). Absorption from SC depots is generally slower and more sustained than IM administration.
T
6 termsTachyphylaxis
A rapid, reversible reduction in response to a compound following repeated or continuous exposure, resulting from receptor downregulation, desensitization, or depletion of downstream signaling intermediaries. In GH secretagogue research, tachyphylaxis is most pronounced with GHRP-6 and Hexarelin at the pituitary GHS-R1a receptor under continuous stimulation. Ipamorelin is studied specifically because its GH-releasing action appears less susceptible to tachyphylaxis, making it useful for longer-duration protocols.
Telomerase
A ribonucleoprotein reverse transcriptase comprising a catalytic protein subunit (TERT) and an RNA template component (TERC), which adds TTAGGG hexanucleotide repeats to eroding chromosome telomeres. Telomerase activity counteracts replicative telomere shortening and is a central research topic in cellular senescence and ageing biology. Epithalon (AEDG tetrapeptide) has been investigated in published in vitro studies examining hTERT expression and telomere dynamics in human somatic cell preparations.
Related Products
Terminus Modification
A chemical alteration applied to the N- or C-terminus of a peptide to modulate its pharmacological properties. C-terminal amidation replaces the free carboxyl group with an amide (-NH2), improving resistance to carboxypeptidases and often increasing receptor affinity. N-terminal acetylation blocks aminopeptidase access. Both modifications can shift the peptide's isoelectric point and solubility profile. The combined effect is typically improved metabolic stability and extended effective half-life.
TGF-Beta Superfamily
Transforming Growth Factor-Beta superfamily, a large family of structurally related dimeric signalling proteins including TGF-betas, bone morphogenetic proteins (BMPs), activins, and growth differentiation factors (GDFs). All family members signal through heteromeric serine/threonine kinase receptor complexes and downstream SMAD transcription factors. GDF-8 (Myostatin), ACE-031, and Follistatin 344 are all investigated within the context of this pathway.
Related Products
Toll-Like Receptor (TLR)
A family of transmembrane pattern recognition receptors (TLR1-TLR13 in mammals) expressed on innate immune cells and epithelial surfaces. TLRs detect conserved pathogen-associated molecular patterns (PAMPs) including bacterial lipopolysaccharide (TLR4), flagellin (TLR5), and unmethylated CpG DNA (TLR9), initiating downstream MyD88-dependent and TRIF-dependent inflammatory signalling cascades. Thymosin Alpha-1 has been examined in published studies for its interaction with TLR2, TLR5, and TLR9 signalling in dendritic cell preparations.
Related Products
TrkB Receptor
Tropomyosin receptor kinase B, a receptor tyrosine kinase and the principal high-affinity receptor for BDNF and neurotrophin-4/5. TrkB activation initiates PI3K/Akt, MAPK/ERK, and PLCgamma signalling cascades governing neuronal survival, axonal and dendritic growth, and long-term potentiation. TrkB-mediated signalling is a primary research endpoint in published in vitro studies with Semax, ADAMAX, and P21.
Related Products
U
1 termsUPLC (Ultra-Performance Liquid Chromatography)
A chromatographic technique derived from HPLC that employs sub-2-micron particle stationary phases operated at pressures exceeding 15,000 psi. The reduced particle size provides substantially greater chromatographic resolution and peak capacity, shorter run times, and improved sensitivity compared with conventional HPLC. In peptide quality control, UPLC is increasingly deployed in MS-UPLC configurations to provide rapid, high-resolution identity and purity confirmation from a single analytical run.
V
1 termsVial
A sealed glass container used to store and ship lyophilized research compounds. Research peptide vials are typically Type I borosilicate glass, sealed with a rubber stopper and aluminium crimp cap. The stopper allows needle access for solvent injection during reconstitution without breaching the sealed headspace. Vials should be inspected for damage, label accuracy, and correct lot number before use and cross-referenced against the corresponding COA.
Related Products
Ready to Browse Our Peptide Catalogue?
Every compound in our catalogue is independently HPLC verified and ships with a batch-specific Certificate of Analysis from our US facility.
Browse Peptides